Navigation Links
Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH
Date:12/8/2008

Soliris is the first therapy approved in Europe for the treatment of PNH and was the first medicinal product to receive EC approval under the EMEA Accelerated Assessment Procedure.

Important Safety Information

Soliris is generally well tolerated. The most frequent adverse events observed in clinical studies were headache, nasopharyngitis (a runny nose), back pain and nausea. Treatment with Soliris should not alter anticoagulant management because the effect of withdrawal of anticoagulant therapy during Soliris treatment has not been established.

The U.S. product label for Soliris also includes a boxed warning: "Soliris increases the risk of meningococcal infections. Vaccinate patients with a meningococcal vaccine at least two weeks prior to receiving the first dose of Soliris; revaccinate according to current medical guidelines for vaccine use. Monitor patients for early signs of meningococcal infections, evaluate immediately if infection is suspected, and treat with antibiotics if necessary." During clinical studies, two out of 196 vaccinated PNH patients treated with Soliris experienced a serious meningococcal infection.

Prior to beginning Soliris therapy, all patients and their prescribing physicians are enrolled in the Soliris Safety Registry, which is part of a special risk-management program that involves initial and continuing education and long-term monitoring for detection of new safety findings.

Please see full prescribing information at www.soliris.net.

About Alexion

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Alexion is engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with a wide arra
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody
2. Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
3. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
4. Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin
5. GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP
6. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
7. GEN Reports on the Trend Toward Predictive Toxicogenomics
8. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
9. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
10. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
11. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... -- CVS Caremark Corporation (NYSE: CVS ) today ... dividend of $0.275 (27.5 cents) per share on the corporation,s ... to holders of record on July 21, 2014. ... to helping people on their path to better health as ... States . Through the company,s more than 7,600 CVS/pharmacy ...
(Date:1/15/2014)... Jan. 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic ... . (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) ... policy support, China,s orthopedic instrument ... total market size rising from 3.28 billion yuan in ...
(Date:1/15/2014)... Jan. 15, 2014 As health officials across the Midwest ... Meijer pharmacies in Michigan will offer ... patients, enabling Meijer pharmacists to administer tests and, in some ... a physician participating in the study. The ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... a voluntary nationwide recall of the three lots listed below of the following product: ... l oi de Injection , USP, 0 . ... V i alsN DC# 0 5 1 ... recall, initiated on March 15, 2011 to the User Level, is for the following lots of ...
... Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of ... testing, said today that it will showcase its ... with the military to develop earlier diagnosis of ... Awareness Day on Capitol Hill in Washington, D.C. ...
Cached Medicine Technology:American Regent Initiates Voluntary Nationwide Recall of Bacteriostatic Sodium Chloride Injection, USP, 0.9% 30 mL Multiple Dose Vials 2American Regent Initiates Voluntary Nationwide Recall of Bacteriostatic Sodium Chloride Injection, USP, 0.9% 30 mL Multiple Dose Vials 3Neuro Kinetics to Showcase I-Portal® Research at Brain Injury Awareness Day on Capitol Hill 2
(Date:7/11/2014)... The “Proteomics Market by Technology (Protein ... Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & ... studies the major market drivers, restraints, and opportunities ... of the World (RoW). , The proteomics market ... years, mainly due to the increasing need of ...
(Date:7/11/2014)... the best available treatment for patients, from a range ... for taxpayers than the existing clinical trial process, a ... carried out while he was a member of the ... based at The University of Manchester,s Health eResearch Centre, ... ) today (Friday 11 July) looked at the use ...
(Date:7/11/2014)... With the arrival of summer, VisitandCare.com ... surgery and hair transplant procedures, up 80 percent from ... of medical tourism destinations, the company is helping patients ... and achieve the look they have always desired. ... name in the medical tourism industry, VisitandCare.com is comprised ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Recently, Fadhits.com, the ... assortment of kids prom dresses . To bring more ... firm has also launched a special offer for these brand ... 25, 2014. , The company’s sales manager says gladly, “We ... this special offer is to acknowledge all new and old ...
(Date:7/11/2014)... Francisco shows that an "expressive therapy" group intervention ... with HIV disclose their health status and improves ... quality of their relationships., "Medication alone is totally ... Machtinger, MD, director of the Women,s HIV Program ... are on effective antiretroviral therapy but far too ...
Breaking Medicine News(10 mins):Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 2Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 3Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 4Health News:Better use of electronic health records makes clinical trials less expensive 2Health News:VisitandCare.com Reports Increase in Cosmetic and Hair Transplant Procedures for Men 2Health News:VisitandCare.com Reports Increase in Cosmetic and Hair Transplant Procedures for Men 3Health News:Promotion for Kids Prom Dresses Now Provided at Fadhits.com 2Health News:'Expressive therapy" intervention assists women living with HIV 2
... , MILLERSVILLE, Md., June 2 Travel Advantage Network ... spring morning to support the National Alliance for Research ... kilometers of it. , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090602/DC26325 ) ... support the charity by completing a 2.5K sponsored walk at ...
... Royal Philips Electronics (NYSE: ... Trilogy100 portable at-home life-support ventilator. The highly versatile, ... milestone in home ventilation from a recognized leader in ... for noninvasive ventilation nearly 20 years ago. , ...
... 2 More than 17 million U.S. children live more ... a life-saving pediatric trauma center, according to a new study ... University of Pennsylvania . The creation of a national ... locations of gaps and greatly improve access to care for ...
... new procedure , TUESDAY, June ... involves sewing together the sides of the stomach holds ... suggest preliminary findings from a clinical trial. , The ... the stomach from relaxing to accept food. This reduces ...
... Pa., June 2 Governor Edward G. Rendell ... the Lottery-funded PACENET prescription drug benefit for older Pennsylvanians, providing ... no drug coverage now. , , "As older ... times, providing comprehensive prescription medication coverage is more important than ...
... Monitor for pest control operators helps control bed bug ... BioSensory, Inc., manufacturer of environmentally-sensitive pest management products ... insects, announces the release of its NightWatch(TM) Bedbug Monitor ... to use to detect bed bug infestations at the ...
Cached Medicine News:Health News:A Little Bit of Leg Work Goes a Long Way for Travel Advantage Network and Mental Health Charity 2Health News:Photos: Philips Expands Home Healthcare Commitment With Portable Life-Support Ventilator; Offers Ease of Use, Portability and Versatility for Patient 2Health News:Photos: Philips Expands Home Healthcare Commitment With Portable Life-Support Ventilator; Offers Ease of Use, Portability and Versatility for Patient 3Health News:17 Million U.S. Children Live More Than an Hour Away From Trauma Care 2Health News:17 Million U.S. Children Live More Than an Hour Away From Trauma Care 3Health News:Weight-Loss Surgery Simplified 2Health News:Governor Rendell Proposes Offering Prescription Help to 30,000 More Older Adults as Part of Plan to Save $60 Million 2Health News:New Product Detects Early Bed Bug Infestations 2Health News:New Product Detects Early Bed Bug Infestations 3
Inquire...
... These high-power, apochromatically corrected ... satisfy the most exacting ... They are suitable for ... to 25 mm and ...
... a higher numerical aperture and superior contrast. ... surface,reflections and provides an image with higher ... fluorescence, brightfield and DIC observation techniques. This ... allows it to be used with immersion ...
The KL 2500 LCD is Schott's most powerful cold light source which makes it ideal for special applications. A 250W halogen reflector lamp provides more than twice as much light as the KL 1500 LCD....
Medicine Products: